These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

884 related items for PubMed ID: 17926235

  • 21. Glucose metabolism in patients with essential hypertension.
    García-Puig J, Ruilope LM, Luque M, Fernández J, Ortega R, Dal-Ré R, AVANT Study Group Investigators.
    Am J Med; 2006 Apr; 119(4):318-26. PubMed ID: 16564774
    [Abstract] [Full Text] [Related]

  • 22. Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease.
    Heldgaard PE, Olivarius Nde F, Hindsberger C, Henriksen JE.
    Diabet Med; 2004 Apr; 21(4):363-70. PubMed ID: 15049940
    [Abstract] [Full Text] [Related]

  • 23. The impact of diabetes or elevated fasting blood glucose on cardiovascular prognosis in patients with stable angina pectoris.
    Held C, Björkander I, Forslund L, Rehnqvist N, Hjemdahl P.
    Diabet Med; 2005 Oct; 22(10):1326-33. PubMed ID: 16176191
    [Abstract] [Full Text] [Related]

  • 24. Impaired fasting glycaemia and undiagnosed diabetes: prevalence, cardiovascular and behavioural risk factors.
    Lecomte P, Vol S, Cacès E, Lasfargues G, Combe H, Laurent S, Tichet J.
    Diabetes Metab; 2002 Sep; 28(4 Pt 1):311-20. PubMed ID: 12442069
    [Abstract] [Full Text] [Related]

  • 25. Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D).
    Saaristo T, Moilanen L, Jokelainen J, Korpi-Hyövälti E, Vanhala M, Saltevo J, Niskanen L, Peltonen M, Oksa H, Cederberg H, Tuomilehto J, Uusitupa M, Keinänen-Kiukaanniemi S.
    Prim Care Diabetes; 2010 Dec; 4(4):231-9. PubMed ID: 21134669
    [Abstract] [Full Text] [Related]

  • 26. Prevalence of type 2 diabetes among patients with hypertension under the care of 30 Italian clinics of hypertension: results of the (Iper)tensione and (dia)bete study.
    Lonati C, Morganti A, Comarella L, Mancia G, Zanchetti A, IPERDIA Study Group.
    J Hypertens; 2008 Sep; 26(9):1801-8. PubMed ID: 18698215
    [Abstract] [Full Text] [Related]

  • 27. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study.
    Valdés S, Botas P, Delgado E, Alvarez F, Cadórniga FD.
    Diabetes Care; 2007 Sep; 30(9):2258-63. PubMed ID: 17536076
    [Abstract] [Full Text] [Related]

  • 28. Diabetes screening in primary care: the PRE.DI.CO. study.
    Bonaccorsi G, Guarducci S, Ruffoli E, Lorini C.
    Ann Ig; 2012 Sep; 24(6):527-34. PubMed ID: 23234190
    [Abstract] [Full Text] [Related]

  • 29. Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria.
    Boronat M, Varillas VF, Saavedra P, Suárez V, Bosch E, Carrillo A, Nóvoa FJ.
    Diabet Med; 2006 Feb; 23(2):148-55. PubMed ID: 16433712
    [Abstract] [Full Text] [Related]

  • 30. Levels of plasma fibrinogen and d-dimer in patients with impaired fasting glucose.
    Coban E, Sari R, Ozdogan M, Akcit F.
    Exp Clin Endocrinol Diabetes; 2005 Jan; 113(1):35-7. PubMed ID: 15662593
    [Abstract] [Full Text] [Related]

  • 31. Screening for diabetes, impaired glucose tolerance, and cardiovascular risk in primary care: a Northland, New Zealand pilot study.
    White B, Chamberlain N.
    N Z Med J; 2009 May 22; 122(1295):28-37. PubMed ID: 19648984
    [Abstract] [Full Text] [Related]

  • 32. Criteria for previously undiagnosed diabetes and risk of mortality: 15-year follow-up of the Edinburgh Artery Study cohort.
    Wild SH, Smith FB, Lee AJ, Fowkes FG.
    Diabet Med; 2005 Apr 22; 22(4):490-6. PubMed ID: 15787678
    [Abstract] [Full Text] [Related]

  • 33. Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran lipid and glucose study.
    Harati H, Hadaegh F, Tohidi M, Azizi F.
    Diabetes Res Clin Pract; 2009 Jul 22; 85(1):90-5. PubMed ID: 19414206
    [Abstract] [Full Text] [Related]

  • 34. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, Wong TY, McNeil J, Shaw JE.
    Circulation; 2007 Jul 10; 116(2):151-7. PubMed ID: 17576864
    [Abstract] [Full Text] [Related]

  • 35. Undetected type 2 diabetes in older adults.
    Dankner R, Geulayov G, Olmer L, Kaplan G.
    Age Ageing; 2009 Jan 10; 38(1):56-62. PubMed ID: 19008303
    [Abstract] [Full Text] [Related]

  • 36. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.
    McLaughlin T, Abbasi F, Lamendola C, Reaven G.
    Arch Intern Med; 2007 Apr 09; 167(7):642-8. PubMed ID: 17420421
    [Abstract] [Full Text] [Related]

  • 37. Prevalence of abnormal urinary albumin excretion rate in hypertensive patients with impaired fasting glucose and its association with cardiovascular disease.
    Marín R, Rodríguez P, Tranche S, Redón J, Morales-Olivas F, Galgo A, Brito MA, Mediavilla J, Lozano JV, Filozof C, MAGAL group.
    J Am Soc Nephrol; 2006 Dec 09; 17(12 Suppl 3):S178-88. PubMed ID: 17130259
    [Abstract] [Full Text] [Related]

  • 38. Ethnic differences in the prevalence of new and known diabetes mellitus, impaired glucose tolerance, and impaired fasting glucose. Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand.
    Sundborn G, Metcalf P, Scragg R, Schaaf D, Dyall L, Gentles D, Black P, Jackson R.
    N Z Med J; 2007 Jun 29; 120(1257):U2607. PubMed ID: 17632597
    [Abstract] [Full Text] [Related]

  • 39. Ethnic differences in cardiovascular disease risk factors and diabetes status for Pacific ethnic groups and Europeans in the Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand.
    Sundborn G, Metcalf PA, Gentles D, Scragg RK, Schaaf D, Dyall L, Black P, Jackson R.
    N Z Med J; 2008 Sep 05; 121(1281):28-39. PubMed ID: 18797481
    [Abstract] [Full Text] [Related]

  • 40. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M, Cortez-Dias N, Martins S, Belo A, VALSIM study investigators.
    Rev Port Cardiol; 2008 Dec 05; 27(12):1495-529. PubMed ID: 19280993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.